Aevitas Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Aevitas Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$134K	Hold	22,000	–	–	0.08%	114
2022 Q3	$130K	Hold	22,000	–	–	0.1%	108
2022 Q2	$130K	Hold	22,000	–	–	0.09%	109
2022 Q1	$168K	Hold	22,000	–	–	0.1%	116
2021 Q4	$60K	Sell	22,000 -150	-0.7%	-$512	0.04%	122
2021 Q3	$58K	Hold	22,150	–	–	0.04%	123
2021 Q2	$91K	Hold	22,150	–	–	0.06%	123
2021 Q1	$104K	Hold	22,150	–	–	0.07%	118
2020 Q4	$158K	Hold	22,150	–	–	0.12%	114
2020 Q3	$236K	Sell	22,150 -1,000	-4%	-$11.7K	0.19%	94
2020 Q2	$292K	Hold	23,150	–	–	0.27%	84
2020 Q1	$212K	Hold	23,150	–	–	0.24%	91
2019 Q4	$323K	Hold	23,150	–	–	0.3%	88
2019 Q3	$398K	Hold	23,150	–	–	0.4%	71
2019 Q2	$630K	Sell	23,150 -14,000	-38%	-$320K	0.63%	47
2019 Q1	$711K	Sell	37,150 -11,150	-23%	-$145K	0.63%	45
2018 Q4	$454K	Sell	48,300 -14,023	-23%	-$180K	0.46%	60
2018 Q3	$1.18M	Sell	62,323 -11,000	-15%	-$211K	1.07%	25
2018 Q2	$1.43M	Hold	73,323	–	–	1.39%	17
2018 Q1	$1.38M	Sell	73,323 -11,000	-13%	-$238K	1.38%	18
2017 Q4	$1.4M	Buy	+84,323	New	+$1.45M	1.33%	21

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Aevitas Wealth Management's VYGR Position: Q4 2022 in Review

Aevitas Wealth Management held its Voyager Therapeutics (VYGR) position steady in Q4 2022 at 22,000 shares worth $134K. The position accounts for 0.08% of the portfolio, ranked #114.

Aevitas Wealth Management first reported a position in VYGR in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.43M in Q2 2018. 70 funds tracked by Wall St. Rank hold VYGR as of Q4 2022.

Aevitas Wealth Management held 22,000 shares of Voyager Therapeutics worth $134K as of Q4 2022.
Aevitas Wealth Management left its Voyager Therapeutics share count unchanged in Q4 2022.
Voyager Therapeutics made up 0.08% of Aevitas Wealth Management's portfolio in Q4 2022, its #114 holding.
Aevitas Wealth Management first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 21 quarters since.
Aevitas Wealth Management's Voyager Therapeutics position peaked at $1.43M in Q2 2018.
70 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2022.

Based on Aevitas Wealth Management's 13F filing for Q4 2022, filed 24 Jan 2023.